Recombinant DNA Advisory Committee- 9/12-13/94 
Others: 
Paul Aebersold, Food and Drug Administration 
Sandra Afiome, Johns Hopkins University 
Abass Alavi, University of Pennsylvania 
Jane Alavi, University of Pennsylvania 
Stephen Albelda, University of Pennsylvania 
Tom Alonzo, GenVec, Inc. 
Robert Anderson, Food and Drug Administration 
W. French Anderson, University of Southern California 
Carlos Arteaga, Vanderbilt University 
Estuardo Aguilar, Baylor College of Medicine 
Robert Beall, Cystic Fibrosis Foundation 
Bari Bialos, New York Hospital 
Bridget Binko, Cell Genesys 
John Bishop, Food and Drug Administration 
Gary Boch, Life Technologies, Inc. 
Ernst Boehnlein, Progenesys 
Arindam Bose, Pfizer Central Research 
Andrew Braun, Harvard University 
Gracia Buffleben, Breast Cancer Action 
Parris Burd, Food and Drug Administration 
James Bylund, Quality Biotech 
Ira Carmen, University of Illinois 
Barry Carter, Targeted Genetics Corporation 
Jan Chappell, Genetic Therapy, Inc. 
Saswati Chatteijee, City of Hope National Medical Center 
Yawen Chiang, Genetic Therapy, Inc. 
Carol Conrad, Johns Hopkins University 
Ronald Crystal, New York Hospital 
Kenneth Culver, Iowa Methodist University 
Karen Darcy, Magenta Corporation 
Wanda de Vlaminck, Avigen 
Blythe Devlin, Duke University 
Lori Doyle, University of Pennsylvania 
Anne Driscoll, Fox, Bennett, & Turner 
Stephen Eck, University of Pennsylvania 
Jim Embree, Systemix 
Suzanne Epstein, Food and Drug Administration 
Terry Flotte, Johns Hopkins University 
Jeffrey Fox, Private Journalist 
Joyce Frey, Food and Drug Administration 
Ingo Georgoff, Quality Biotech 
Eva Giesan, French Cystic Fibrosis Association 
Christine Ginsberg, Georgetown University 
Recombinant DNA Research, Volume 20 
[13] 
